Inhibitory Effect of Fucoidan on TGF-β1-Induced Activation of Human Pulmonary Fibroblasts
![]() |
Yim, Mi-Jin
(Natural Products Research Team, National Marine Biodiversity Institute of Korea)
Lee, Dae-Sung (Natural Products Research Team, National Marine Biodiversity Institute of Korea) Choi, Grace (Natural Products Research Team, National Marine Biodiversity Institute of Korea) Lee, Jeong Min (Natural Products Research Team, National Marine Biodiversity Institute of Korea) Choi, Il-Whan (Department of Microbiology and Immunology, College of Medicine Inje University) |
1 | Tanaka K, Ishihara T, Azuma A, Kudoh S, Ebina M, Nukiwa T, Sugiyama Y, Tasaka Y, Namba T, Ishihara T, Sato K, Mizushima Y and Mizushima T. 2010. Therapeutic effect of lecithinized superoxide dismutase on bleomycininduced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 298, L348-L360. http://dx.doi.org/10.1152/ajplung.00289.2009. DOI |
2 | Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C and Brown RA. 2002. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3, 349-363. http://dx.doi.org/10.1038/nrm809. DOI |
3 | Wang Q, Wang Y, Hyde DM, Gotwals PJ, Koteliansky VE, Ryan ST and Giri SN. 1999. Reduction of bleomycin induced lung fibrosis by transforming growth factor beta solublereceptor in hamsters. Thorax 54, 805-812. DOI |
4 | Park KH, Cho EH, Kim NC and Chae HJ. 2010. Production of Fucoidan Using Marine Algae. KSBB Journal 25, 223-229. |
5 | Ahmed AB, Adel M, Karimi P and Peidayesh M. 2014. Pharmaceutical, cosmeceutical, and traditional applications of marine carbohydrates. Adv Food Nutr Res 73, 197-222. http://dx.doi.org/10.1016/B978-0-12-800268-1.00010-X. DOI |
6 | Ahluwalia N, Shea BS and Tager AM. 2014. New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses. Am J Respir Crit Care Med 190, 867-878. http://dx.doi.org/10.1164/rccm.201403-0509PP. DOI |
7 | Antoniou KM, Margaritopoulos GA and Siafakas NM. 2013. Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future. Eur Respir Rev 22, 281-291. http://dx.doi.org/10.1183/09059180.00002113. DOI |
8 | Camelo A, Dunmore R, Sleeman MA and Clarke DL. 2014. The epithelium in idiopathic pulmonary fibrosis: breaking thebarrier. Front Pharmacol 4, 173. http://dx.doi.org/10.3389/fphar.2013.00173. DOI |
9 | Blobe GC, Schiemann WP and Lodish HF. 2000. Role of transforming growth factor beta in human disease. N Engl J Med 342, 1350-1358. http://dx.doi.org/10.1056/NEJM200005043421807. DOI |
10 | Broekelmann TJ, Limper AH, Colby TV and McDonald JA. 1991. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 88, 6642-6646. DOI |
11 | Fries KM, Felch ME and Phipps RP. 1994. Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets. Am J Respir Cell Mol Biol 11, 552-560. http://dx.doi.org/10.1165/ajrcmb.11.5.7946384. DOI |
12 | Cho Y, Yoon JH, Yoo JJ, Lee M, Lee DH, Cho EJ, Lee JH, Yu SJ, Kim YJ and Kim CY. 2015. Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43. Acta Pharm Sin B 5, 544-553. http://dx.doi.org/10.1016/j.apsb.2015.09.004. DOI |
13 |
Coker RK, Laurent GJ, Shahzeidi S, HernandezRodriguez NA, Pantelidis P, du Bois RM, Jeffery PK and McAnulty RJ. 1996. Diverse cellular |
14 | Cottin V. 2016. Idiopathic interstitial pneumonias with connectivetissue diseases features: A review. Respirology 21, 245-258. http://dx.doi.org/10.1111/resp.12588. DOI |
15 | Guo B, Inoki K, Isono M, Mori H, Kanasaki K, Sugimoto T, Akiba S, Sato T, Yang B, Kikkawa R, Kashiwagi A, Haneda M and Koya D. 2005. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells. Kidney Int 68, 972-984. http://dx.doi.org/10.1111/j.1523-1755.2005.00491.x. DOI |
16 | King TE, Costabel U, Cordier JF, Dopoco GA, Bois RM, Lynch D, Myers J, Panos R, Raghu G, Schwartz D and Smith CM. 2000. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161, 646-664. http://dx.doi.org/10.1164/ajrccm.161.2.ats3-00. DOI |
17 | Hinz B. 2007. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127, 526-537. http://dx.doi.org/10.1038/sj.jid.5700613. DOI |
18 |
Hu B, Wu Z and Phan SH. 2003. Smad3 mediates transforming growth factor- |
19 | Jin JO, Zhang W, Du JY, Wong KW, Oda T and Yu Q. 2014. Fucoidan can function as an adjuvant in vivo to enhance dendritic cell maturation and function and promote antigenspecific T cell immune responses. PLoS One 9, e99396. http://dx.doi.org/10.1371/journal.pone.0099396. DOI |
20 | Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH and Greenberg AH. 1991. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 5, 155-162. DOI |
21 | King TE Jr, Pardo A and Selman M. 2011. Idiopathic pulmonary fibrosis. Lancet 378, 1949-1961. http://dx.doi.org/10.1016/S0140-6736(11)60052-4. DOI |
22 | Kuznetsova TA, Besednova NN, Somova LM and Plekhova NG. 2014. Fucoidan extracted from Fucus evanescens prevents endotoxin-induced damage in a mouse model of endotoxemia. Mar Drugs 12, 886-898. http://dx.doi.org/10.3390/md12020886. DOI |
23 | Leask A and Abraham DJ. 2004. TGF-beta signaling and the fibrotic response. FASEB J 18, 816-827. http://dx.doi.org/10.1096/fj.03-1273rev. DOI |
24 |
Pan R, Zhang Y, Zang B, Tan L and Jin M. 2016. Hydroxysafflor yellow A inhibits TGF- |
25 |
Luo F, Zhuang Y, Sides MD, Sanchez CG, Shan B, White ES and Lasky JA. 2014. Arsenic trioxide inhibits transforming growth factor- |
26 | Moore MW and Herzog EL. 2013. Regulation and Relevance of Myofibroblast Responses in Idiopathic Pulmonary Fibrosis. Curr Pathobiol Rep 1, 199-208. http://dx.doi.org/10.1007/s40139-013-0017-8. DOI |
27 | O'Leary R, Rerek M and Wood EJ. 2004. Fucoidan modulates the effect of transforming growth factor (TGF)-beta1 on fibroblast proliferation and wound repopulation in in vitro models of dermal wound repair. Biol Pharm Bull 27, 266-270. DOI |
28 | Park KY, Back JH, Hur W and Lee SY. 2007. In vitro glucose and bile acid retardation effect of fucoidan from Laminaria japonica. Kor J Biotechnol Bioeng 4, 265-269. |
29 | Pedroza M, Schneider DJ, Karmouty-Quintana H, Coote J, Shaw S, Corrigan R, Molina JG, Alcorn JL, Galas D, Gelinas R and Blackburn MR. 2011. Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury. PLoS ONE 6, e22667. http://dx.doi.org/10.1371/journal.pone.0022667. DOI |
30 | Raghu G, Weycker D, Edelsberg J, Bradford WZ and Oster G. 2006. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174, 810-816. http://dx.doi.org/10.1164/rccm.200602-163OC. DOI |
![]() |